The global metabolomics market is witnessing steady expansion driven by rising demand for precision medicine, biomarker ...
More and more scientists are taking advantage of DNA microarray chip technology to further their research. PubMed can give a rough estimate of the growth and acceptance of this technology; a search ...
Agilent Technologies (A) and Danaher (DHR) screen as potential buyers of Qiagen (QGEN) after a report that the European molecular testing firm is weighing its options after takeover interest. "QGEN ...
Molecular Diagnostics Market Size Is Expected To Reach USD 43.50 Billion By 2035 Owing To The Surging Demand For Accurate And Early Disease Detection Globally SNS Insider. U.S. Molecular Diagnostics ...
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life ...
Two powerful tumor suppressor genes, p53 and FUS1, administered intravenously in nanoparticle formulations are capable of shrinking metastatic tumors in models of human lung cancer. with the Breaking ...